• Reported GAAP EPS of -$0.10 up 9.09% YoY • Reported revenue of $0.26M down -69.36% YoY • For the full year 2026, Quantum-Si reiterated financial guidance for revenue of approximately $1M, adjusted total operating expenses of $98M or less, and total cash usage of $93M or less.
Bullish
Quantum-Si achieved key Proteus development milestones, including successful sequencing and customer sample processing, while reducing adjusted operating expenses and maintaining a strong cash position of $190.4M, supporting operations into Q2 2028.
Bearish
Quantum-Si faced a significant Q1 2026 revenue decline to $258,000 from $842,000 in Q1 2025, alongside an increased net loss of $21.7M, with guidance reflecting intentional tradeoffs impacting near-term revenue.